Infections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents

Nucci, Marcio, Anaissie, Elias·2009·Clinical Infectious Diseases

DOI 10.1086/605664

Cited by (346)

Items 101–200 of 346

Infectious complications in multiple myeloma receiving autologous stem cell transplantation in the past 10 years
Hyunkyung Park, Jeonghwan Youk, Hak Ro Kim, Youngil Koh, Ji Hyun Kwon, Sung‐Soo Yoon, Seonyang Park, Pyoeng Gyun Choe, Nam Joong Kim, Myoung‐don Oh et al. · 2017 · International Journal of Hematology
Severe cytomegalovirus enterocolitis developing following daratumumab exposure in three patients with multiple myeloma
Noa Lavi, Doaa Okasha, Edmond Sabo, Ilana Oren, Noam Benyamini, Haggai Bar‐Yoseph · 2018 · European Journal Of Haematology
Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple Myeloma
Guido Lancman, Katleen S. Lozada, Nida Athar, Samantha E. Jacobs, John T. Doucette, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, Samir Sunil Parekh, Shambavi Richard et al. · 2021 · Clinical Lymphoma Myeloma & Leukemia
Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study
Roy Vitkon, Dan Netanely, Shai Levi, Tomer Ziv‐Baran, Ronit Ben-Yzak, Ben‐Zion Katz, Noam Benyamini, Svetlana Trestman, Moshe Mittelman, Yael Chava Cohen et al. · 2021 · Therapeutic Advances in Hematology
Poor Correlation between Pneumococcal IgG and IgM Titers and Opsonophagocytic Activity in Vaccinated Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia
Johanna Karlsson, Lucy Roalfe, Harriet Hogevik, Marta Zancolli, Björn Andréasson, David Goldblatt, Christine Wennerås · 2016 · Clinical and Vaccine Immunology
Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma
Asher Alban Chanan-Khan, Sagar Lonial, Donna Weber, Ivan Borrello, Robin Foà, Andrzej Rafal Hellmann, Meletios Athanasios Dimopoulos, Arlene S. Swern, Robert Knight · 2012 · International Journal of Hematology
Surgical Management of Multiple Myeloma With Symptomatic Involvement of the Spine
Helena Milavec, Nivetha Ravikumar, Nicholas L. X. Syn, Cinnie Yentia Soekojo, Wee Joo Chng, Naresh Kumar · 2020 · The International Journal of Spine Surgery
Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients
E. Mai, T. Hielscher, U. Bertsch, H. Salwender, S. Zweegman, Marc-Steffen Raab, M. Munder, L. Pantani, K. Mancuso, P. Brossart et al. · 2023 · Leukemia
Pneumococcal vaccine responses in elderly patients with multiple myeloma, Waldenstrom’s macroglobulinemia, and monoclonal gammopathy of undetermined significance
Johanna Karlsson, Harriet Hogevik, Kerstin Andersson, Leyla Roshani, Björn Andréasson, Christine Wennerås · 2013 · Trials in Vaccinology
Risk factors and epidemiology of C lostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period
Sol Del Mar Aldrete, Colleen S. Kraft, Matthew James Magee, Austin W. Chan, Don Hutcherson, Amelia A. Langston, Brian I. Greenwell, Eileen M. Burd, Rachel Friedman‐Moraco · 2016 · Transplant Infectious Disease
Ruminococcus gnavus bacteraemia in a patient with multiple haematological malignancies
Caroline Gren, Malene Roed Spiegelhauer, Emelie Curovic Rotbain, Boje Kvorning Ehmsen, Peter Kampmann, Leif Percival Andersen · 2019 · Access Microbiology
Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single‐institution study
Francesco Marchesi, Fulvia Pimpinelli, Maria Laura Dessanti, Svitlana Gumenyuk, Francesca Palombi, Francesco Pisani, A. Romano, Antonio Spadea, Marta C.E. Maschio, Fabrizio Ensoli et al. · 2014 · Transplant Infectious Disease
Immune alterations in untreated and treated multiple myeloma
Constantin A Dasanu · 2011 · Journal of Oncology Pharmacy Practice
Efficacy-safety of Facilitated Subcutaneous Immunoglobulin in Immunodeficiency Due to Hematological Malignancies. A Single-Center Retrospective Analysis
Maria Dimou, Theodore Iliakis, Dimitrios Maltezas, Aikaterini Bitsani, Sotiria Kalyva, Aspasia Koudouna, Sotiria Kotsanti, Panayiota Petsa, Paraskevi Papaioannou, Marie‐Christine Kyrtsonis et al. · 2018 · Anticancer Research
Mobilization and Exercise Intervention for Patients With Multiple Myeloma: Clinical Practice Guidelines Endorsed by the Canadian Physiotherapy Association
Deepa Jeevanantham, Venkadesan Rajendran, Zachary McGillis, Line Tremblay, Céline Larivière, Andrew Knight · 2020 · Physical Therapy
Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib.
Toshihiro Fukushima, Tomomi Sato, Takuji Nakamura, Haruka Kawanami Iwao, Akio Nakajima, Miyuki Miki, Tomoyuki Sakai, Takafumi Kawanami, Toshioki Sawaki, Yoshimasa Fujita et al. · 2012 · PubMed
Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant
Andrea Mengarelli, Ombretta Annibali, Fulvia Pimpinelli, Elisabetta Riva, Svitlana Gumenyuk, D. Renzi, Elisabetta Cerchiara, Livia Piccioni, Francesca Palombi, Francesco Pisani et al. · 2015 · Journal of Infection
Drug-Induced Modulation of T Lymphocytes as a Potential Mechanism of Susceptibility to Infections in Patients with Multiple Myeloma During Bortezomib Therapy
Juan Li, Ying Li, Beihui Huang, Dong Zheng, Mei Chen, Zhenhai Zhou · 2014 · Cell Biochemistry and Biophysics
Diagnosis and therapy of multiple myeloma
Antonio Pierangelo Palumbo, Chiara Cerrato · 2013 · The Korean Journal of Internal Medicine
Early Postoperative Outcomes After Total Joint Arthroplasty in Patients With Multiple Myeloma
Mariano E. Menendez, Kwan Jun Park, Charles Lowry Barnes · 2016 · The Journal of Arthroplasty
Megatrends in Infectious Diseases: The Next 10 to 15 Years
Sin Yew Wong, Ban Hock Tan · 2019 · Annals of the Academy of Medicine Singapore
Antibiotic prophylaxis for patients with newly diagnosed multiple myeloma: Systematic review and meta‐analysis
Ghulam Rehman Mohyuddin, Muhammad Aziz, Brian Lee McClune, Al-Ola A. Abdallah, Muzaffar H. Qazilbash · 2019 · European Journal Of Haematology
Infectious Complications in Patients With Multiple Myeloma After High-Dose Chemotherapy Followed by Autologous Stem Cell Transplant: Nationwide Study of the Infectious Complications Study Group of the Polish Adult Leukemia Group
Anna Waszczuk‐Gajda, Joanna Ewa Drozd-Sokolowska, Grzegorz Władysław Basak, Agnieszka Piekarska, Patrycja Mensah‐Glanowska, Alicja Sadowska‐Klasa, Agnieszka Wierzbowska, Piotr Rzepecki, Agnieszka Tomaszewska, Joanna Mańko et al. · 2020 · Transplantation Proceedings
The Route of the Malignant Plasma Cell in Its Survival Niche: Exploring “Multiple Myelomas”
Antonio Giovanni Solimando, Matteo Da Vià, Niccolò Bolli, Torsten Steinbrunn · 2022 · Cancers
IMPACT OF PRETRANSPLANT DONOR AND RECIPIENT CYTOMEGALOVIRUS SEROSTATUS ON OUTCOME FOR MULTIPLE MYELOMA PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION.
Jean El Cheikh · 2013 · Mediterranean Journal of Hematology and Infectious Diseases
Imaging of Multiple Myeloma
Barry Amos, Amit Kumar Agarwal, Sangam G. Kanekar · 2016 · Hematology/Oncology Clinics of North America
Infection complications in an unselected cohort of patients with multiple myeloma treated with lenalidomide combinations
Tommaso Caravita, Massimo Offidani, Agostina Siniscalchi, Silvia Gentili, Patrizia Caraffa, Alessio Pio Perrotti, Paolo de Fabritiis, Pietro Leoni · 2012 · European Journal Of Haematology
Novel treatment regimens for Waldenström’s macroglobulinemia
Ramón García‐Sánz, Enrique M. Ocio · 2010 · Expert Review of Hematology
Multiple myeloma: the disease and its treatment
Meenakshi Gupta, R. N. Pal, Deepika Tikoo · 2013 · International Journal of Basic & Clinical Pharmacology
Efficacy of Bortezomib for Treating Anti-Interferon-Gamma Autoantibody-Associated Adult-Onset Immunodeficiency Syndrome
Nasikarn Angkasekwinai, Yupin Suputtamongkol, Wiwit Tantibhedhyangkul, Nattawat Onlamoon, Pakpoom Phoompoung, Manop Pithukpakorn, Ekkapun Karuphong, Pawana Pusuwan, Pornpimon Angkasekwinai · 2023 · Clinical Infectious Diseases
Supportive care in multiple myeloma: Current practices and advances
Teresa S. Miceli, Wilson I. Gonsalves, Francis K. Buadi · 2021 · Cancer Treatment and Research Communications
Burkholderia multivorans: A rare yet emerging cause of bacterial meningitis
Diego P Peralta, Aymara Y. Chang, Angie Ariza‐Hutchinson, Catherine A. Ho · 2018 · IDCases
Prevention of Infections in Patients with Hematological Malignancies
Márcio Nucci, Elias J. Anaissie · 2017 · Springer eBooks
The risk factors for herpes zoster in bortezomib treatment in patients with multiple myeloma
Yang-Seon Yi, Joo-Seop Chung, Moo-Kon Song, Ho‐Jin Shin, Young‐Mi Seol, Young Jin Choi, Goon-Jae Cho, Gyeong‐Won Lee, Joon Ho Moon, In-Hye Hwang et al. · 2010 · The Korean Journal of Hematology
Impact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for multiple myeloma
J.H. Kim, Claudia Goulston, Maurizio Zangari, Guido J. K. Tricot, Michael W. Boyer, Kimberly E. Hanson · 2014 · Transplant Infectious Disease
Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China
Junru Liu, He Huang, Yan Li, Lin Liu, Jianyong Li, Zhuogang Liu, Jin Lu, Jian Ouyang, Yongping Song, Daobin Zhou et al. · 2015 · Tumor Biology
Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma
Katja Christina Weisel, Meletios Athanasios Dimopoulos, Philippe Moreau, Münci Yağcı, Alessandra Larocca, Abraham Sebastian Kanate, Filiz Vural, Nicola Cascavilla, Supratik Basu, Peter R. E. Johnson et al. · 2020 · Leukemia & lymphoma/Leukemia and lymphoma
Early T-Cell Precursor Leukemia Has a Higher Risk of Induction-Related Infection among T-Cell Acute Lymphoblastic Leukemia in Adult
Kangyu Huang, Min Dai, Qiuli Li, Nannan Liu, Dainan Lin, Qiang Wang, Xuan Zhou, Zhixiang Wang, Ya Gao, Hua Jin et al. · 2020 · Mediators of Inflammation
Infections in secondary immunodeficiency patients treated with Privigen®or Hizentra®: a retrospective US administrative claims study in patients with hematological malignancies
Rajiv Mallick, Victoria M. Divino, Bruce Douglas Smith, Stephen R.A. Jolles, Mitch DeKoven, Donald Cuong Vinh · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma
Josbert M. Metselaar, Twan Lammers, Amelie Boquoi, Roland R. Fenk, Fabio J. Testaquadra, Mirle Schemionek, Fabian M. Kiessling, Susanne Isfort, Stefan Wilop, Martina Margrit Crysandt · 2023 · Drug Delivery and Translational Research
Diarrhea in Multiple Myeloma: A Review of the Literature
Beth M Faiman · 2016 · Clinical journal of oncology nursing
Multiple Myeloma Vaccination Patterns in a Large Health System: A Pilot Study
Andinet Worku Alemu, Maharaj Singh, Chris Blumberg, John O. Richards, Martin K. Oaks, Michael A. Thompson · 2017 · Journal of patient-centered research and reviews
Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma
Yutaka Tsukune, Makoto Sasaki, Norio Komatsu · 2019 · Cancers
Brain abscess caused byNocardia cyriacigeorgicain two patients with multiple myeloma: novel agents, new spectrum of infections
Merve Pamukçuoğlu, Hakan Emmez, Özlem Güzel Tunçcan, Ali Yusuf Öner, Meltem Yalınay Çırak, Esin Şenol, Gülsan Türköz Sucak · 2013 · Hematology
Visceral leishmaniasis infection in a refractory multiple myeloma patient treated with bortezomib
Eugenio Piro, Mariagrazia Kropp, Renato Cantaffa, Angelo Giuseppe Lamberti, Guido Carillio, Stefano Molica · 2012 · Annals of Hematology
Preemptive intravenous immunoglobulin allows safe and timely administration of antineoplastic therapies in patients with multiple myeloma and parvovirus B19 disease
Lakshmikanth Katragadda, Zainab Shahid, Alejandro Restrepo, Jameel Muzaffar, Daisy V. Alapat, Elias J. Anaissie · 2013 · Transplant Infectious Disease
CD4+ T Cell Dependent B Cell Recovery and Function After Autologous Hematopoietic Stem Cell Transplantation
Clarissa Heck, Sophie Steiner, Eva M. Kaebisch, Marco Frentsch, Friedrich Wittenbecher, Carmen Scheibenbogen, Leif G. Hanitsch, Axel Nogai, Philipp le Coutre, Lars Bullinger et al. · 2021 · Frontiers in Immunology
Effect of underlying immune compromise on the manifestations and outcomes of group A streptococcal bacteremia
Kathleen A. Linder, Leen Alkhouli, Mayur S. Ramesh, George John Alangaden, Carol A. Kauffman, Marisa H. Miceli · 2017 · Journal of Infection
Clinical significance of cancer-related fatigue in multiple myeloma patients
Kazuhito Suzuki, Nobuyuki Kobayashi, Yoji Ogasawara, Takaki Shimada, Yuichi Yahagi, Katsuki Sugiyama, Shinobu Takahara, Takeshi Saito, Jiro Minami, Hiroki Yokoyama et al. · 2018 · International Journal of Hematology
Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel – ABHH monoclonal gammopathies committe
Vânia Hungria, Marcia Maiolino Garnica, Edvan de Queiroz Crusoé, Roberto Josè Pessoa de Magalhães Filho, Gracia Martınez, Rosane Bittencourt, Danielle Leão Cordeiro de Farias, Walter Moisés Tobias Braga, Jorge Vaz Pinto Neto, Glaciano Ribeiro et al. · 2020 · Hematology Transfusion and Cell Therapy
Immunoglobulin G treatment of secondary immunodeficiencies in the era of novel therapies
Mikko R. J. Seppänen · 2014 · Clinical & Experimental Immunology
Cellular mechanisms associated with sub-optimal immune responses to SARS-CoV-2 bivalent booster vaccination in patients with Multiple Myeloma
Adolfo Aleman, Morgan van Kesteren, Ariel Kogan Zajdman, Komal Srivastava, Christian Cognigni, Jacob Mischka, Lucia Chen, Bhaskar Upadhyaya, Kseniya Serebryakova, Jessica Nardulli et al. · 2023 · EBioMedicine
Risk assessment and clinical implications of COVID-19 in multiple myeloma patients: A systematic review and meta-analysis
Sultan Abu Saleh Mahmud, Md Faruk Hossain, Abdul Muyeed, Shaila Nazneen, Md. Ashraful Haque, Harun Mazumder, Md Mohsin · 2024 · PLoS ONE
Nocardia intracranial mycotic aneurysm associated with proteasome inhibitor
Siriththin Chansirikarnjana, Anucha Apisarnthanarak, Nuntra Suwantarat, Pansachee Damronglerd, Sasinuch Rutjanawech, Suttichai Visuttichaikit, Thana Khawcharoenporn · 2019 · IDCases
Palliative Care in Patients With Multiple Myeloma
Renato Verayo Samala, Jason Neil Valent, Natalee Noche, Ruth L. Lagman · 2019 · Journal of Pain and Symptom Management
The impact of changed treatment patterns in multiple myeloma on health‐care utilisation and costs, myeloma complications, and survival: A population‐based comparison between two time periods in Denmark
Louise Hur Hannig, Lene Kongsgaard Nielsen, Rikke Ibsen, Lisen Arnheim‐Dahlström, Jakob Kjellberg, Niels Abildgaard · 2021 · European Journal Of Haematology
Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China
Yufeng Shang, Weida Wang, Yuxing Liang, Natasha Mupeta Kaweme, Qian Wang, Minghui Liu, Xiaoqin Chen, Zhongjun Xia, Fuling Zhou · 2022 · Frontiers in Oncology
Intestinal Klebsiella pneumoniae Contributes to Pneumonia by Synthesizing Glutamine in Multiple Myeloma
Yihui Wang, Qin Zhao Yang, Yinghong Zhu, Xingxing Jian, Jiaojiao Guo, Jingyu Zhang, Chunmei Kuang, Xiangling Feng, Gang An, Lugui Qiu et al. · 2022 · Cancers
Going the distance: Are we losing patients along the multiple myeloma treatment pathway?
Evangelos Terpos, Florence Suzan, Hartmut Goldschmidt · 2018 · Critical Reviews in Oncology/Hematology
Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival
RAO H. PRABHALA, William E. Pierceall, Mehmet Samur, Lakshmi B. Potluri, Kevin Hong, Teresa Peluso, Srikanth Talluri, Angela Yee‐Moon Wang, Aishwarya Katiki, Sahan D. Vangala et al. · 2023 · Frontiers in Oncology
An emergency medicine review: Multiple myeloma and its complications
Brit Long, Arleigh B. Robertson McCurdy, Alex Koyfman, Hans Rosenberg · 2024 · The American Journal of Emergency Medicine
Evaluation of the Relevance of Surgery in Patients with Multiple Myeloma Harboring Symptomatic Spinal Involvement: A Retrospective Case Series
Mathilde Quidet, Fahed Zaïri, Eileen Mary Boyle, Thierry T.F. Facon, Marie-Hélène Vieillard, François Machuron, Jean‐Paul Lejeune, Richard Assaker · 2018 · World Neurosurgery
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
Claudio Cerchione, Davide Nappi, Giovanni Martinelli · 2021 · Supportive Care in Cancer
Infectious complications in patients with newly diagnosed multiple myeloma: A complication from the past?
Javier de la Rubia, María José Cejalvo, Paz Ribas · 2015 · Leukemia & lymphoma/Leukemia and lymphoma
Post-treatment improvement of NK cell numbers predicts better survival in myeloma patients treated with thalidomide-based regimens
Jorge Vela‐Ojeda, Miriam America Garcia-Ruiz Esparza, Abraham Majluf‐Cruz, Jaime Garcı́a-Chávez, Laura Arcelia Montiel‐Cervantes, Elba Reyes‐Maldonado, Álvaro Hernández-Caballero, Maria Guadalupe Rodríguez-González · 2019 · International Journal of Hematology
Native aortic valve endocarditis with Morganella morganii in a patient with multiple myeloma and valvular amyloidosis: a case report
Renée van Bentum, Judith Nieken, Esther de Waal, Mels Hoogendoorn · 2019 · BMC Infectious Diseases
Infections After High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation
Márcio Nucci, Elias J. Anaissie · 2014 · Springer eBooks
B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients
Robéria Mendonça de Pontes, Juan A Flores-Montero, Luzalba Sanoja-Flores, Noemí Puig, Roberto Magalhães, Alba Corral-Mateos, Anna Beatriz Salgado, Omar García-Sánchez, José Juan Pérez, María‐Victoria Mateos et al. · 2021 · Cancers
Brain abscesses caused by Nocardia paucivorans in a multiple myeloma patient treated with lenalidomide and dexamethasone: a case report and review of literature.
Jacopo Monticelli, Roberto Luzzati, Cristina Maurel, Chiara Rosin, Romina Valentinotti, Claudio Farina · 2014 · Mediterranean Journal of Hematology and Infectious Diseases
Potential roles of microRNAs and their target genes in human multiple myeloma
Yong Yang, Jisheng Lin, Zhao Ma, Jinjun Li, Dong Li, Bingqiang Wang, Fei Qi · 2017 · European Journal Of Haematology
Infections in patients with mantle cell lymphoma
Kossi Abalo, Sara Ekberg, Therése Andersson, Simon Pahnke, Alexandra Albertsson‐Lindblad, Karin Ekstrom Ekstroem Smedby, Mats Jerkeman, Ingrid Cecilia Glimelius · 2024 · HemaSphere
Prevention Strategies to Minimize the Infection Risk Associated with Biologic and Targeted Immunomodulators
Elaheh Kordzadeh-Kermani, Hossein Khalili, Iman Karimzadeh, Mohammadreza Salehi · 2020 · Infection and Drug Resistance
Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management
Ilaria J. Chicca, Jennifer L. J. Heaney, Gulnaz Iqbal, Janet Dunn, Stella J. Bowcock, Guy Pratt, Kwee Yong, Tim Planche, Alex G Richter, Mark Trehane Drayson · 2020 · Blood Cancer Journal
Practical guidance on the prevention and management of infection in multiple myeloma patients: A case-based approach
Aarthi Kannan, K. Jeffrey, Siraj Misbah, Karthik Ramasamy · 2025 · Blood Reviews
Use of antifungal drugs in hematology
Márcio Nucci · 2012 · Revista Brasileira de Hematologia e Hemoterapia
Treatment of Human Respiratory Syncytial Virus infected Balb/C mice with the proteasome inhibitor bortezomib (Velcade®, PS-341) results in increased inflammation and mortality
Christopher R. Lupfer, Kristin M. Patton, Manoj K. Pastey · 2009 · Toxicology
Bacteremias following autologous stem cell transplantation for multiple myeloma: Risk factors and outcomes
Meera Mohan, Sandra P. Susanibar-Adaniya, Amy F. Buros, Juan Carlos Rico Crescencio, Mary J. Burgess, Katherine T. Lusardi, Faith E. Davies, Gareth John Morgan, Frits Vanrhee, Maurizio Zangari et al. · 2019 · Transplant Infectious Disease
Antibiotic Prophylaxis or Granulocyte-Colony Stimulating Factor Support in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Eva-Maria Klein, Sandra Sauer, Sabrina Klein, Diana Tichy, Axel Benner, Uta Bertsch, Juliane Brandt, Christoph Richard Kimmich, Hartmut Goldschmidt, Carsten Müller‐Tidow et al. · 2021 · Cancers
Visceral leishmaniasis in a patient with relapsed multiple myeloma receiving high-dose melphalan and autologous stem cell transplant
Aleksandar Radujkovic, Michael Hundemer, Christoph Eisenbach, Thomas Luft, Roland Penzel, Hartmut Goldschmidt, Anthony Dick Ho, Frauke Bellos · 2014 · Leukemia & lymphoma/Leukemia and lymphoma
Szczepienia ochronne u dorosłych chorych na nowotwory hematologiczne oraz u chorych z asplenią – zalecenia PTHiT i sekcji do spraw zakażeń PALG
Iwona Hus, Agnieszka Piekarska, Jacek Roliński, Katarzyna Brzeźniakiewicz‐Janus, Krzysztof Giannopoulos, Krzysztof Jamroziak, Beata Piątkowska‐Jakubas, Agnieszka Wierzbowska, Jan Maciej Zaucha, Sebastian Giebel et al. · 2018 · Acta Haematologica Polonica
Prolonged Severe Watery Diarrhea in a Long-Term Myeloma Survivor: An Unforeseen Infection with Cystoisospora belli
Tarık Onur Tiryaki, Kadir Uluç Anıl, Melek Büyük, Ahmet Yasir Yıldırım, Alp Atasoy, Aslı Çiftçibaşi Örmeci, Sevgi Kalayoğlu Beşışık · 2020 · Turkish Journal of Hematology
IL-32 is induced by activation of toll-like receptors in multiple myeloma cells
Kristin Roseth Aass, Synne Stokke Tryggestad, Robin Mjelle, Martin H. Kastnes, Tonje Marie Vikene Nedal, Kristine Misund, Therese Standal · 2023 · Frontiers in Immunology
Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021
Kai Kysenius, Anna Anttalainen, Iiro Toppila, Tatu A. Miettinen, Mariann Ida Lassenius, Juha Lievonen, Anu Partanen, Raija Helena Silvennoinen, Mervi Putkonen · 2024 · Annals of Hematology
Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature
Nengwen Xu, Linjie Li, Wen Lei, Wenbin Qian · 2021 · Brain Sciences
Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimen
Su-In Kim, Sung‐Hoon Jung, Ho‐Young Yhim, Jae‐Cheol Jo, Ga‐Young Song, Mihee Kim, Seo‐Yeon Ahn, Jae‐Sook Ahn, Deok‐Hwan Yang, Hyeoung‐Joon Kim et al. · 2022 · Blood Research
The advanced lung cancer inflammation index predicts chemotherapy response and infection risk in multiple myeloma patients receiving induction chemotherapy
Jie Cheng, Qianyuan Li, Sheng Xiao, Lu Nie, Jianping Liao, Qingjie Jiang, Biyu Xiang, Hongfei Zhang, Yan‐Hong Jiang, Chenjiao Yao · 2022 · Frontiers in Genetics
Executive summary of consensus clinical practice guidelines for the prevention of infection in patients with multiple myeloma
Benjamin W. Teh, Gemma K. Reynolds, Monica A. Slavin, Louise Cooley, Matthew Blake Roberts, Eunice Liu, Karin Thursky, Dipti Talaulikar, Peter N. Mollee, Ferenc Szabó et al. · 2023 · Internal Medicine Journal
Pneumococcal native aortic valve endocarditis with mycotic abdominal aortic aneurysm, paraspinal and iliopsoas abscesses and pneumonia revealing a multiple myeloma
Jasper Fuk‐Woo Chan, Gloria Hwang, Sophia S. Lamb, Gavin S. W. Chan, Jason C. C. So, Sally S. M. Leung, Kelvin Kai‐Wang To, Iris W. S. Li, Vincent Chi‐Chung Cheng, Kwok‐Yung Yuen · 2011 · Journal of Medical Microbiology
Pulmonary Nocardiosis in a Multiple Myeloma Patient Treated with Proteasome Inhibitors
Nikolai P. Mendonca, Deepak K. K. Kadayakkara, Inga C. Forde, Anastasiia Rudkovaskaia, Zane K. Saul, David Lobo · 2016 · American Journal of Case Reports
Intractable hiccups due to herpetic esophagitis in an immunocompromised patient
John Harris, Tukisa Smith, Jana I. Preis · 2016 · IDCases
CYTOMEGALOVIRUS RETINITIS AFTER TREATMENT WITH LENALIDOMIDE FOR MULTIPLE MYELOMA
Hui Yin Lim, David Francis, Jonathan Yeoh, Lyndell L. Lim · 2013 · Retinal Cases & Brief Reports
High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for ‘late effects’ screening and preventive strategies
Clare Samuelson, Laurence O’Toole, Elaine G. Boland, David Greenfield, Yousef Ezaydi, Sam Hjelmeland Ahmedzai, John Andrew Snowden · 2016 · Hematology
Actualización en el diagnóstico y manejo de aspergilosis invasora en pacientes adultos
Ricardo Rabagliati B · 2018 · Revista chilena de infectología
Intravenous immunoglobulin prophylaxis is associated with decreased rate of infection‐related hospitalizations in multiple myeloma patients
Michael Sheu, Sofia Molina Garcia, Meera H. Patel, Lauren M. Granat, Louis S. Williams, Jack Khouri, Sherif Beniameen Mossad, Faiz Anwer, Aneela Majeed · 2023 · Hematological Oncology
The treatment outcome of multiple myeloma patients ineligible for hematopoietic transplantation—a single institutional experience in Taiwan
Tzu-Chuan Huang, Jia-Hong Chen, Yi‐Ying Wu, Ping‐Ying Chang, Ming‐Shen Dai, Tsu-Yi Chao, Woei‐Yau Kao, Yeu‐Chin Chen, Ching‐Liang Ho · 2014 · Annals of Hematology
Fighting the flu in multiple myeloma
A. John Barrett · 2011 · Blood
Phase II, Multicenter, Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of Panobinostat in Combination with Bortezomib and Dexamethasone in Japanese Patients with Relapsed or Relapsed-and-Refractory Multiple Myeloma
Kenshi Suzuki, Kazutaka Sunami, Morio Matsumoto, Akio Maki, Fumika Shimada, Kazuyuki Suzuki, Kazuyuki Shimizu · 2020 · Acta Haematologica
Immune responses to COVID ‐19 booster vaccinations in intensively anti‐CD38 antibody treated patients with ultra‐high‐risk multiple myeloma: results from the Myeloma UK ( MUK) nine OPTIMUM trial
Sian Elizabeth Faustini, Andrew Hall, Sarah Brown, Sadie Roberts, Harriet J. Hill, Zania Stamataki, Matthew W. Jenner, Roger G. Owen, Guy Pratt, Gordon Cook et al. · 2023 · British Journal of Haematology
Ophthalmic manifestations of herpes zoster virus in patients with multiple myeloma following bone marrow transplantation
Alhossain A. Khalafallah, Miriam Woodgate, Kurien Koshy, Andrew Patrick · 2013 · BMJ Case Reports
Bone marrow B lymphocytes in multiple myeloma and MGUS: Focus on distribution of naïve cells and memory subsets
Fanny Pojero, Alessandra Casuccio, Caterina Giambanco, Matteo Bulati, Silvio Buffa, Francesco Di Bassiano, Francesco Gervasi, Calogero Caruso, Giuseppina Colonna Romano · 2016 · Leukemia Research